Injection time-dependent effect of adult human bone marrow stromal cell transplantation in a rat model of severe traumatic brain injury

Current Stem Cell Research and Therapy

Volumn 8, Issue 2, 2013, Pages 172-181

  Han, Eun Young ^a   Chun, Min Ho ^b   Kim, Sang Tae ^b   Lim, Dong pyo ^b  

^a Jeju National University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Human bone marrow stromal cells; Injection timing; Traumatic brain injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN;

ACUTE DISEASE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BONE MARROW CELL; BONE MARROW STROMAL CELL; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMISPHERE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INJECTION; MACROGLIA; MALE; MAZE TEST; MORTALITY; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; ROTAROD TEST; STROMA CELL; TRAUMATIC BRAIN INJURY;

ADULT; ADULT STEM CELLS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HOUSING, ANIMAL; HUMANS; INJECTIONS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MAZE LEARNING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROGLIA; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST; TIME FACTORS;

EID: 84875606564     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308020008     Document Type: Article

References (48)

1. Ugoya SO, Tu J. Bench to Bedside of Neural Stem Cell in Traumatic Brain Injury. Stem Cells Int 2012; 2012: 141624.
2. Anonymous. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Trauma systems. J Neurotrauma 2000; 17: 457-62.
3. Goldman SA. Adult neurogenesis: from canaries to the clinic. J Neurobiol 1998; 36(2): 267-86.
4. Gage FH. Neurogenesis in the adult brain. J Neurosci 2002; 22: 612-3.
5. Kirschenbaum B, Nedergaard M, Preuss A, Barami K, Fraser RA, Goldman SA. In vitro neuronal production and differentiation by precursor cells derived from the adult human forebrain. Cereb Cortex 1994; 4: 576-89.
6. Pincus DW, Keyoung HM, Harrison-Restelli C, et al. Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells. Ann Neurol 1998; 43: 576-85.
7. Roy NS, Wang S, Jiang L, et al. In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med 2000; 6: 271-7.
8. Sanai N, Tramontin AD, Quinones-Hinojosa A, et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 2004; 427: 740-4.
9. Chen X, Katakowski M, Li Y, et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 2002; 69: 687-91.
10. Mahmood A, Lu D, Lu M, Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 2003; 53: 697-702; discussion -3.
11. Mahmood A, Lu D, Qu C, Goussev A, Chopp M. Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats. Neurosurgery 2005; 57: 1026-31; discussion - 31.
12. Mahmood A, Lu D, Yi L, Chen JL, Chopp M. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg 2001; 94: 589-95.
13. Kang SH, Chun MH, Kim ST, Cho HJ. Human mesenchymal stem cells derived from bone marrow in traumatic brain injury of rat migrate to the site of injury. J Korean Acad Rehab Med 2009; 33: 520-6.
14. Thompson HJ, Lifshitz J, Marklund N, et al. Lateral fluid percussion brain injury: a 15-year review and evaluation. J Neurotrauma 2005; 22: 42-75.
15. Humphreys BD, Duffield JD, Bonventre JV. Renal stem cells in recovery from acute kidney injury. Minerva Urol Nefrol 2006; 58: 13-21.
16. Koide Y, Morikawa S, Mabuchi Y, et al. Two distinct stem cell lineages in murine bone marrow. Stem Cells 2007; 25: 1213-21.
17. Sykova E, Jendelova P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ 2007; 14: 1336-42.
18. Fujimoto ST, Longhi L, Saatman KE, Conte V, Stocchetti N, McIntosh TK. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci Biobehav Rev 2004; 28: 365-78.
19. Dezawa M, Hoshino M, Nabeshima Y, Ide C. Marrow stromal cells: implications in health and disease in the nervous system. Curr Mol Med 2005; 5: 723-32.
20. Haas S, Weidner N, Winkler J. Adult stem cell therapy in stroke. Curr Opin Neurol 2005; 18: 59-64.
21. Levy YS, Stroomza M, Melamed E, Offen D. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. J Mol Neurosci 2004; 24: 353-86.
22. Sohur US, Emsley JG, Mitchell BD, Macklis JD. Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1477-97.
23. Taupin P. Adult neurogenesis in mammals. Curr Opin Mol Ther 2006; 8: 345-51.
24. Moseley TA, Zhu M, Hedrick MH. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 2006; 118: 121S-8S.
25. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 2006; 13: 77-81.
26. Tholpady SS, Llull R, Ogle RC, Rubin JP, Futrell JW, Katz AJ. Adipose tissue: stem cells and beyond. Clin Plast Surg 2006; 33: 55-62, vi.
27. Teng L, Labosky PA. Neural crest stem cells. Adv Exp Med Biol 2006; 589: 206-12.
28. Watt FM, Lo Celso C, Silva-Vargas V. Epidermal stem cells: an update. Curr Opin Genet Dev 2006; 16: 518-24.
29. Morigi M, Benigni A, Remuzzi G, Imberti B. The regenerative potential of stem cells in acute renal failure. Cell Transplant 2006; 15 Suppl 1: S111-7.
30. Elfenbein GJ. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose? Pediatr Transplant 2005; 9 Suppl 7: 37-47.
31. Fruehauf S, Seeger T, Topaly J. Innovative strategies for PBPC mobilization. Cytotherapy 2005; 7: 438-46.
32. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 2006; 44: 215-30.
33. Sottile V. Bone marrow as a source of stem cells and germ cells? Perspectives for transplantation. Cell and tissue research 2007; 328: 1-5.
34. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81-8.
35. Yoo JU, Barthel TS, Nishimura K, et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998; 80: 1745-57.
36. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18: 1417-26.
37. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998; 16: 406-13.
38. Xiong Y, Qu C, Mahmood A, et al. Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats. Brain Res 2009; 1263: 183-91.
39. Kabadi SV, Hilton GD, Stoica BA, Zapple DN, Faden AI. Fluidpercussion- induced traumatic brain injury model in rats. Nat Protoc 2010; 5: 1552-63.
40. Fitch MT, Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp Neurol 1997; 148: 587-603.
41. Cafferty WBJ, Yang SH, Duffy PJ, Li S, Strittmatter SM. Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 2007; 27: 2176-85.
42. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999; 49: 377-91.
43. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA. Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 1996; 17: 595-606.
44. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005; 2: 8.
45. Tu Z, Li Q, Bu H, Lin F. Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev 2010; 19: 1803-9.
46. Yang HS, Chun MH, Kim DK, Kim ST, Jo HJ. Neuroprotective Effect of Exogenous Growth Hormone in Brain Injury-Rat Model. J Korean Acad Rehab Med 2006; 30: 333-9.
47. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302: 1760-5.
48. Heile A, Brinker T. Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1. Dialogues Clin Neurosci 2011; 13: 279.